The Xa Factor : Pushing Back on Atherosclerosis by Yasuhiro Maejima
Research Video
Paper Information
Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression
Yusuke Ito, Yasuhiro Maejima, Shun Nakagama, Yuka Shiheido-Watanabe, Natsuko Tamura and Tetsuo Sasano
Publication: JACC: Basic to Translational Science, 2021 Dec 27;6(12):964-980.
Publication Date: Published 2021 December 27 DOI: 10.1016/j.jacbts.2021.09.010
Yusuke Ito, Yasuhiro Maejima, Shun Nakagama, Yuka Shiheido-Watanabe, Natsuko Tamura and Tetsuo Sasano
Publication: JACC: Basic to Translational Science, 2021 Dec 27;6(12):964-980.
Publication Date: Published 2021 December 27 DOI: 10.1016/j.jacbts.2021.09.010
Correspondence to
Yasuhiro Maejima, Associate Professor
E-mail: ymaeji.cvm(at)tmd.ac.jp
Department of Cardiovascular Medicine,
Graduate School of Medical and Dental Sciences,
Tokyo Medical and Dental University(TMDU)
＊Please change (at) in e-mail addresses to @ on sending your e-mail to contact personnels.
E-mail: ymaeji.cvm(at)tmd.ac.jp
Department of Cardiovascular Medicine,
Graduate School of Medical and Dental Sciences,
Tokyo Medical and Dental University(TMDU)
＊Please change (at) in e-mail addresses to @ on sending your e-mail to contact personnels.